Funtleyder on Lilly's Alzheimer's Drug
Oct. 9 (Bloomberg) -- Les Funtleyder, president of the investment advisory division at Poliwogg, talks about Eli Lilly & Co.'s experimental Alzheimer's treatment, the Alzheimer's drug market and the outlook for Lilly and PDL BioPharma Inc.
He speaks with Pimm Fox on Bloomberg Television's "Taking Stock." Bloomberg's Shannon Pettypiece also speaks. (Source: Bloomberg)